Bisphosphonates in osteoporosis: recent clinical experience

Area of Science:

• Pharmacology
• Endocrinology
• Orthopedics

Background:

• Bisphosphonates are key inhibitors of bone resorption.
• They are widely used for osteoporosis and metabolic bone disorders.
• Bisphosphonates are crucial in managing skeletal issues from corticosteroid therapy.

Purpose of the Study:

• To review the role of bisphosphonates in bone health.
• To highlight their efficacy in fracture prevention and bone loss management.
• To discuss challenges in patient selection and adherence.

Main Methods:

• Review of current clinical applications and evidence for bisphosphonates.
• Analysis of bisphosphonate efficacy in various patient populations.
• Discussion of safety profiles and treatment strategies.

Main Results:

• Bisphosphonate therapy significantly reduces vertebral and non-vertebral fractures in high-risk women.
• They serve as effective alternatives to estrogen for preventing bone loss in younger postmenopausal women.
• Bisphosphonates are the preferred treatment for preventing skeletal complications of chronic corticosteroid use.

Conclusions:

• Bisphosphonates are well-tolerated and have an excellent safety profile when used appropriately.
• Identifying suitable candidates and optimizing dosing/monitoring are crucial for long-term adherence.
• Effective management strategies are needed to maximize the benefits of bisphosphonate therapy.